Decoy Therapeutics Inc. cotiza a 1.24 USD y tiene una capitalización bursátil de $3M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical pepti…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-4.46 | $-4.18 | $43.10 | $-21.72 |
| Estimado | $-2.88 | $-4.08 | $-6.48 | $-8481.60 |
| Sorpresa | -54.9% | -2.5% | +765.1% | +99.7% |
| Métrica | DCOY | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -212.6% | -40.4% | -172.2% |
| ROA | -113.2% | -32.0% | -81.2% |
| Current Ratio | 2.13 | 2.84 | -0.71 |
| Debt / Equity | — | 0.28 | — |